Nuveen Asset Management, LLC Caribou Biosciences, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 330,831 shares of CRBU stock, worth $817,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
330,831
Previous 267,735
23.57%
Holding current value
$817,152
Previous $522,000
0.77%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
43.9MCall Options Held
25KPut Options Held
53.2K-
Black Rock Inc. New York, NY6.95MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$10.1 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.07MShares$7.58 Million0.46% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.27MShares$5.61 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$4.47 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $150M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...